Yingju Xu

2.0k citations

21 papers · 1.1k indexed · 1 hit paper · h-index 17

Organic Chemistry top 2%
- Asymmetric Synthesis and Catalysis 3
- Catalytic C–H Functionalization Methods 2
Inorganic Chemistry top 5%
Molecular Biology
- Chemical Synthesis and Analysis 8
- Protein Kinase Regulation and GTPase Signaling 3
- Biochemical and Structural Characterization 3
Microbiology top 10%
Pharmaceutical Science top 10%
Infectious Diseases
- HIV/AIDS drug development and treatment 3
Immunology
- Toxin Mechanisms and Immunotoxins 3
Pharmacology
- Microbial Natural Products and Biosynthesis 2

Co-authors: Scott J. Miller Elizabeth A. Colby Davie Steven M. Mennen Bianca R. Sculimbrene Joseph Barbieri Chad A. Lewis Mark McLaughlin Robert A. Reamer
Cited by: Organic Chemistry Inorganic Chemistry Molecular Biology
Partner nations: United States Russia China

In The Last Decade

Yingju Xu

20 papers receiving 1.1k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Yingju Xu

Since Specialization

Citations

This map shows the geographic impact of Yingju Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingju Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingju Xu more than expected).

Fields of papers citing papers by Yingju Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingju Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingju Xu. The network helps show where Yingju Xu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yingju Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yingju Xu Line = papers co-authored together Yingju Xu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Process Development toward a Key Fragment of the PCSK9 Inhibitor Enlicitide Decanoate Kai‐Jiong Xiao,Qinghao Chen,Yingju Xu,Gao Shang,Lushi Tan,Fangzhou Xie,Chengqian Xiao,Yongpeng Yuan,Baoqiang Wan,Guiquan Liu,Jingjun Yin	2025	0
2	Development of a Commercial Manufacturing Route to 2-Fluoroadenine, The Key Unnatural Nucleobase of Islatravir Cynthia Hong,Yingju Xu,John Y. L. Chung,Danielle M. Schultz,Mark Weisel,Richard J. Varsolona,Yong‐Li Zhong,Akasha K. Purohit,Cyndi Qixin He,Donald R. Gauthier,Guy R. Humphrey,Kevin M. Maloney,François Lévesque,Zhixun Wang,Aaron M. Whittaker,E. B. Sirota,Jonathan P. McMullen	2020	16
3	Synthesis of Islatravir Enabled by a Catalytic, Enantioselective Alkynylation of a Ketone Niki R. Patel,Christopher C. Nawrat,Mark McLaughlin,Yingju Xu,Mark A. Huffman,Hao Yang,Hongming Li,Aaron M. Whittaker,Teresa Andreani,François Lévesque,Anna Fryszkowska,Andrew P. J. Brunskill,David M. Tschaen,Kevin M. Maloney	2020	18
4	Combining traditional 2D and modern physical organic-derived descriptors to predict enhanced enantioselectivity for the key aza-Michael conjugate addition in the synthesis of Prevymis™ (letermovir) Toni T. Metsänen,Katrina W. Lexa,Celine B. Santiago,Cheol K. Chung,Yingju Xu,Zhijian Liu,Guy R. Humphrey,Rebecca T. Ruck,Edward C. Sherer,Matthew S. Sigman	2018	23
5	Asymmetric Hydrogen Bonding Catalysis for the Synthesis of Dihydroquinazoline-Containing Antiviral, Letermovir Cheol K. Chung,Zhijian Liu,Katrina W. Lexa,Teresa Andreani,Yingju Xu,Yining Ji,Daniel A. DiRocco,Guy R. Humphrey,Rebecca T. Ruck	2017	27
6	A Mild Cu(I)-Catalyzed Oxidative Aromatization of Indolines to Indoles Feng Peng,Mark McLaughlin,Yizhou Liu,Ian Mangion,David M. Tschaen,Yingju Xu	2016	22
7	Practical Asymmetric Synthesis of a Chiral Piperazinone Derivative Mark McLaughlin,Kevin M. Belyk,Cheng‐yi Chen,Xin Linghu,Jun Pan,Gang Qian,Robert A. Reamer,Yingju Xu	2013	24
8	Process Development and Large-Scale Synthesis of MK-6186, a Non-Nucleoside Reverse Transcriptase Inhibitor for the Treatment of HIV Adrian Goodyear,Xin Linghu,Brian Bishop,Cheng Chen,Ed Cleator,Mark McLaughlin,Faye J. Sheen,Gavin W. Stewart,Yingju Xu,Jingjun Yin	2012	6
9	Practical Synthesis of Functionalized 1,5-Disubstituted 1,2,4-Triazole Derivatives Yingju Xu,Mark McLaughlin,Emily N. Bolton,Robert A. Reamer	2010	30
10	A General Method for the Synthesis of 3,5-Diarylcyclopentenones via Friedel−Crafts Acylation of Vinyl Chlorides Yingju Xu,Mark McLaughlin,Cheng‐yi Chen,Robert A. Reamer,Peter G. Dormer,Ian W. Davies	2009	16
11	Insights into the Structural Specificity of the Cytotoxicity of 3-Deoxyphosphatidylinositols Yanling K. Wang,Wei Chen,Derek Blair,Mingming Pu,Yingju Xu,Scott J. Miller,Alfred G. Redfield,Thomas C. Chiles,Mary F. Roberts	2008	23
12	Asymmetric Catalysis Mediated by Synthetic Peptidesbreakdown → Elizabeth A. Colby Davie,Steven M. Mennen,Yingju Xu,Scott J. Miller	2007	551
13	Oxidative inhibition of receptor-type protein-tyrosine phosphatase k by ultraviolet irradiation activates epidermal growth factor receptor in human keratinocytes Yingju Xu	2006	15
14	Unified Total Syntheses of the Inositol Polyphosphates: d-I-3,5,6P₃, d-I-3,4,5P₃, d-I-3,4,6P₃, and d-I-3,4,5,6P₄ via Catalytic Enantioselective and Site-Selective Phosphorylation Adam J. Morgan,Shio Komiya,Yingju Xu,Scott J. Miller	2006	36
15	Desymmetrization of Glycerol Derivatives with Peptide-Based Acylation Catalysts Chad A. Lewis,Bianca R. Sculimbrene,Yingju Xu,Scott J. Miller	2005	75
16	Asymmetric Syntheses of Phosphatidylinositol-3-Phosphates with Saturated and Unsaturated Side Chains through Catalytic Asymmetric Phosphorylation Bianca R. Sculimbrene,Yingju Xu,Scott J. Miller	2004	55
17	Preparation of (5α,13α)-d-azasteroids as key precursors of a new family of potential GABAA receptor modulators Cunde Wang,Shaozhong Wang,Yingju Xu,Yuefei Hu,Hongwen Hu	2003	7
18	Pertussis toxin-catalyzed ADP-ribosylation of Gi-2 and Gi-3 in CHO cells is modulated by inhibitors of intracellular trafficking Yingju Xu,Joseph Barbieri	1996	28
19	Pertussis toxin-mediated ADP-ribosylation of target proteins in Chinese hamster ovary cells involves a vesicle trafficking mechanism Yingju Xu,Joseph Barbieri	1995	40
20	Role of histidine 35 of the S1 subunit of pertussis toxin in the ADP-ribosylation of transducin Yingju Xu,V. Barbançon-Finck,J.T. Barbieri	1994	17

About Yingju Xu

Yingju Xu is a scholar working on Physiology, Organic Chemistry and Immunology, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (8 papers), Asymmetric Synthesis and Catalysis (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Biochemical and Structural Characterization (3 papers), HIV/AIDS drug development and treatment (3 papers), Toxin Mechanisms and Immunotoxins (3 papers), Catalytic C–H Functionalization Methods (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). The work is most often cited by research in Organic Chemistry (798 citations), Inorganic Chemistry (207 citations) and Molecular Biology (528 citations). Yingju Xu has collaborated with scholars based in United States, Russia and China. Frequent co-authors include Scott J. Miller, Elizabeth A. Colby Davie, Steven M. Mennen, Bianca R. Sculimbrene, Joseph Barbieri, Chad A. Lewis, Mark McLaughlin, Robert A. Reamer, Adam J. Morgan and Guy R. Humphrey.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact